Stay updated on Neoadj Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Neoadj Pembrolizumab Clinical Trial page.

Latest updates to the Neoadj Pembrolizumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision label changed from v3.4.1 to v3.4.2, with no visible changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision from v3.4.0 to v3.4.1 is shown; core study details and layout appear unchanged.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3. This update does not modify study details or core page content.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section with Minnesota, New Hampshire, and North Carolina. Removed the HHS Vulnerability Disclosure link and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.4%

- Check93 days agoChange DetectedA note was added clarifying that publications listed are automatically filled from PubMed and may not all pertain to the study, and the Revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check100 days agoChange DetectedRemoved the government funding lapse disclaimer from the page; the study details now appear without that notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Neoadj Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj Pembrolizumab Clinical Trial page.